शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEShyama Computronics and Services Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 26 May, 2026 · 15:38 IST

Please find enclosed.

Pat NegativeNegative Operating CashflowEbitda Margin CompressionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.8%Reaction day
₹3.30
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.0%+4.9% vs market
Pharmaceuticals peers, median of 164sector+0.1%+4.8% vs sector

On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 4.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.8-0.0+4.9+0.1+4.8
Next day
+10.0-0.7+10.7-0.6+10.6
2d
+15.5-1.8+17.2-1.3+16.8
3d
+21.2-0.7+21.9-1.4+22.6
4d
+27.3-0.5+27.7-1.6+28.9
5d
+21.2+0.4+20.8-0.6+21.8
1w
+33.6-1.6+35.2-2.3+35.9
15d
+68.2+4.6+63.6+0.0+68.2
1m
+36.4+4.6+31.8+3.0+33.4
2m
-12.7+6.1-18.8+4.4-17.1
3m
—+10.8—+8.6—
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Directors approved the audited standalone financial results for the quarter and year ended 31st March 2026. Total income declined to Rs 38.07 Lacs from Rs 43.17 Lacs in the previous year. Revenue from operations grew modestly by ~13% to Rs 27.93 Lacs, but other income dropped significantly to Rs 10.14 Lacs from Rs 18.49 Lacs. Profit after tax fell to Rs 11.40 Lacs from Rs 14.53 Lacs (a ~21.5% decline). The statutory auditors, A. O. Mittal & Associates LLP, issued an unmodified (clean) audit opinion with no qualifications. The Board also re-appointed Mr. Abhiset Basu as Internal Auditor for FY 2026-27. Cash flow from operating activities was negative at Rs -0.25 Lacs.

Likely market impact

The company reported a decline in profitability despite modest revenue growth, with negative operating cash flow. However, the clean audit opinion and stable balance sheet (total assets ~Rs 8,076 Lacs vs equity ~Rs 1,025 Lacs) indicate no immediate concerns for shareholders.